Most importantly, Fli1 has been shown to be a potent inhibitor of type I collagen production in dermal fibroblasts and persistent downregulation of this transcription factor has been implicated in the pathogenesis of cutaneous fibrosis in scleroderma [12], [19]. This evidence concerns the gene FLI1 and scleroderma.